尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Eva Prieschl-Grassauer, 管理人员. Director active across 1 company, notably Marinomed Biotech AG. In total, 2 reports have been published. Activity tracked since 31 March 2026. The latest transaction was disclosed on 13 April 2026 (Purchase). Regulator: FMA (OeKB OAM). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Eva Prieschl-Grassauer holds an executive position at Marinomed Biotech AG. She is involved in the strategic and operational management of the company, contributing to its development and performance in the biopharmaceutical sector. Her role is essential for the growth of the institution.